Insulin lispro Subcutaneous and Pertuzumab Intravenous
Determining the interaction of Insulin lispro Subcutaneous and Pertuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: pertuzumab
Brand name: Perjeta
Synonyms: Pertuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Pertzye
- Insulin lispro Subcutaneous-Pexeva
- Insulin lispro Subcutaneous-Pexidartinib
- Insulin lispro Subcutaneous-Pexidartinib Hydrochloride
- Insulin lispro Subcutaneous-Pfizerpen
- Insulin lispro Subcutaneous-Pharaon Tea
- Pertuzumab Intravenous-Insulin NPH
- Pertuzumab Intravenous-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Pertuzumab Intravenous-Insulin NPH (Vials)
- Pertuzumab Intravenous-Insulin NPH and Insulin Regular
- Pertuzumab Intravenous-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Pertuzumab Intravenous-Insulin NPH and Insulin Regular (Vials)